Add BrightSurf on Google Email

The Lancet


Folic acid supplements not linked to multiple births

A significant body of evidence suggests that folic acid supplements have no association with an increased likelihood of having a multiple birth. In this large-scale Chinese study, around 240,000 women who used daily folic acid supplements did not show a higher rate of multiple births compared to those who did not use supplements.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJan 30, 2003

Whose interests does the World Trade Organisation serve?

The World Trade Organisation serves the interests of pharmaceutical companies and wealthy countries, hindering efforts to make affordable medicines available in poor countries. A proposed global deal aimed at increasing access to generic drugs has been rejected due to US opposition, prompting calls for a re-evaluation of the issue.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJan 23, 2003

A possible link between IVF and eye cancer?

Dutch researchers found a possible link between IVF and eye cancer in children. The study suggests that IVF children are 5-7 times more likely to develop retinoblastoma, a rare form of childhood eye cancer. Researchers are now calling for closer follow-up and monitoring of IVF-conceived children.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJan 23, 2003

Rapid diagnostic test for plague

A rapid diagnostic test for plague has been developed to detect antigens at low concentrations within 15 minutes of infection. The test is 100% sensitive and reliable, detecting more infections than conventional laboratory assessments and providing opportunities for bioterrorism preparedness and response.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJan 16, 2003

When to screen for diabetic eye disease?

A new study from the Liverpool Diabetic Eye Study has proposed optimal screening intervals for diabetic eye disease, based on incidence data. The findings suggest that patients with no baseline retinopathy should be screened every 3 years, while those with background retinopathy can be screened annually.

SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateJan 16, 2003

Drug advertising in medical journals can be misleading

The study found that nearly half of promotional claims were not supported by corresponding references, with the most common error being recommending treatment to a different patient group than those assessed in the reference study. Doctors should be cautious when assessing advertisements claiming greater efficacy, safety, or convenience.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJan 2, 2003

Stroke in the 21st century

Researchers explore the role of statins in preventing CNS leucocyte accumulation in multiple sclerosis, a condition that increases dementia risk. A review on mild cognitive impairment highlights the urgency to address these disorders.

SourceThe Lancet_DELETED·JournalThe Lancet Neurology·DateDec 19, 2002

Early promise for new antimalarial drug

A new antibiotic, fosmidomycin, has been shown to be effective against the Plasmodium falciparum parasite, with rapid parasite elimination and fever reduction. Cure rates after two weeks were 89%, 88%, and 60% for treatment durations of 5, 4, and 3 days, respectively.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 12, 2002

Call for WHO elections to be more open and transparent

A joint campaign between The Lancet and the Rockefeller Foundation aims to highlight critical issues in WHO's Director-General election, including a pressing need for leadership, funding reform, and prioritizing global health equity. The campaign seeks responses from candidates on key questions and calls for public scrutiny and debate.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 5, 2002

New treatment option for children with cholera

A new study has identified azithromycin as an effective single-dose antibiotic treatment for children with cholera, reducing diarrhoea duration by 24 hours compared to erythromycin. However, the high cost of azithromycin may limit its widespread adoption in treating childhood cholera.

SourceThe Lancet_DELETED·JournalThe Lancet·DateNov 28, 2002

New approach for treating asthma

Researchers found that normalizing induced sputum eosinophil count reduces asthma exacerbations by 63% and severe asthma attacks by 67%. The strategy has implications for regular monitoring of airway inflammation to treat moderate to severe asthma.

SourceThe Lancet_DELETED·JournalThe Lancet·DateNov 28, 2002

Statins benefit older people

A recent study found that pravastatin treatment reduced coronary death, non-fatal heart attack, and fatal or non-fatal stroke by 15% in adults aged 70-82. The benefits were most pronounced for reducing death from heart disease, with a nearly 25% relative risk reduction.

SourceThe Lancet_DELETED·JournalThe Lancet·DateNov 21, 2002

Screening men for aortic aneurysms justified

A new study led by Alan Scott found that screening men for aortic aneurysms can significantly reduce aneurysm-related deaths. The Multicentre Aneurysm Screening Study showed a relative risk reduction of around 50% among screened men, with a corresponding decrease in absolute risk.

SourceThe Lancet_DELETED·JournalThe Lancet·DateNov 14, 2002

Coffee addicts at reduced risk of type 2 diabetes?

A large study of over 17,000 Dutch adults found that those who drank seven or more cups of coffee a day were 50% less likely to develop type-2 diabetes. The study suggests that components of coffee other than caffeine may be beneficial for glucose metabolism, but long-term effects are unknown.

SourceThe Lancet_DELETED·JournalThe Lancet·DateNov 7, 2002

The Lancet Infectious Diseases (TLID)

Quorum sensing allows bacteria to coordinate unified attacks on hosts through the production of virulence factors. Disrupting quorum sensing might be used to control infection. Other reviews discuss athogenesis of coagulase-negative staphylococci, Q fever in children, and testosterone therapy in HIV wasting syndrome.

SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateOct 30, 2002

The Lancet Oncology (TLO)

Imatinib mesylate has shown significant effectiveness in treating gastrointestinal stromal tumours (GISTs), a previously difficult-to-treat cancer type. The drug's success is attributed to its ability to target KIT tyrosine kinase mutations, which are present in most GISTs.

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateOct 30, 2002

Cleaner air linked to reduced death rates

Two studies found that reducing air pollution through coal bans and emission controls leads to significant decreases in mortality rates, particularly for respiratory and cardiovascular diseases. Estimated reductions include 116 respiratory deaths and 243 cardiovascular deaths per year.

SourceThe Lancet_DELETED·JournalThe Lancet·DateOct 17, 2002